Shareholders Equity: The sum of preferred and common equity items.
TuHURA Biosciences, Inc. (HURA) had Shareholders Equity of $14.59M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-22.65M |
|
-- |
|
-- |
|
$17.65M |
|
$-17.65M |
|
$-4.03M |
|
$-21.68M |
|
$-21.68M |
|
$-21.68M |
|
$-21.68M |
|
$-21.68M |
|
$-21.68M |
|
$-17.65M |
|
$-16.25M |
|
18.66M |
|
18.66M |
|
$-1.21 |
|
$-1.21 |
|
| Balance Sheet Financials | |
$19.61M |
|
$0.12M |
|
$0.36M |
|
$19.97M |
|
$5.33M |
|
-- |
|
$0.04M |
|
$5.37M |
|
$14.32M |
|
$14.59M |
|
|
Shareholders Equity |
$14.59M |
42.32M |
|
| Cash Flow Statement Financials | |
$-14.73M |
|
$-6.05M |
|
$29.77M |
|
$3.67M |
|
$12.66M |
|
$8.99M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-151.46% |
|
-148.57% |
|
-108.59% |
|
-148.57% |
|
$0.34 |
|
$-0.79 |
|
$-0.79 |
|